<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02997410</url>
  </required_header>
  <id_info>
    <org_study_id>TCelakil</org_study_id>
    <nct_id>NCT02997410</nct_id>
  </id_info>
  <brief_title>Ozone Therapy for Masticatory Muscle Pain (OTMMP)</brief_title>
  <acronym>OTMMP</acronym>
  <official_title>Effect of High-frequency Bio-oxidative Ozone Therapy for Masticatory Muscle Pain: a Double-blind Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the efficacy of bio-oxidative ozone application in the treatment of
      TMD of muscular origin.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ozone is a natural pale blue gas that can be found in the atmosphere. Medical grade ozone is
      a powerful oxidizing agent which can be produced commercially in ozone generators. Ozone can
      have effects on blood components and positively affect oxygen metabolism, cell energy,
      immunomodulation and microcirculation.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Actual">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Pain Values (kg/cm2) on the Pressure pain threshold measurement (PPT) using a Pressure Algometry at 1 month</measure>
    <time_frame>Change from Baseline Pain Values (kg/cm2) at 1 month</time_frame>
    <description>Patient-reported pain intensity data when the feeling of pressure become painful, at which time the pressure is stopped. Measurements were separated by 30-s rest periods.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Pain Values (kg/cm2) on the Pressure pain threshold measurement (PPT) using a Pressure Algometry at 3 months</measure>
    <time_frame>Change from Baseline Pain Values (kg/cm2) at 3 months</time_frame>
    <description>Patient-reported pain intensity data when the feeling of pressure become painful, at which time the pressure is stopped. Measurements were separated by 30-s rest periods.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Pain Scores on the Visual Analog Scale at 1 month</measure>
    <time_frame>Change from Baseline Pain Scores at 1 month</time_frame>
    <description>The measurement of subjective pain intensity is done using a 100-mm visual analogue scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Pain Scores on the Visual Analog Scale at 3 months</measure>
    <time_frame>Change from Baseline Pain Scores at 3 months</time_frame>
    <description>The measurement of subjective pain intensity is done using a 100-mm visual analogue scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional examination</measure>
    <time_frame>Baseline, 1 month and 3 months</time_frame>
    <description>Functional examination is based on Research Diagnostic Criteria for Temporomandibular Disorder (RDC/TMD) including extra-oral and cervical muscle pains, joint pains, mouth openings, lateral excursions and protrusion. Vertical and horizontal movements are measured with a plastic millimetre-scale ruler. Participants are asked to report any pain during muscle and joint palpation, and this information is recorded using a verbal scale: 0, no pain; 1, mild pain; 2, moderate pain; and 3, severe pain.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Orofacial Pain</condition>
  <condition>Temporomandibular Joint Disorders</condition>
  <arm_group>
    <arm_group_label>Ozone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ozone application to the greatest points of pain in the related muscle, 3 times per week for 2 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Sham ozone application to the greatest points of pain in the related muscle, 3 times per week for 2 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Occlusal splint</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Occlusal splint use every night over a period of 4 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ozone</intervention_name>
    <arm_group_label>Ozone</arm_group_label>
    <other_name>OzonytroneX</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo (for Ozone)</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dental treatment with occlusal splint</intervention_name>
    <arm_group_label>Occlusal splint</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of myofascial pain according to the Research Diagnostic Criteria for
             Temporomandibular Disorder (RDC/TMD)

          -  Natural posterior occlusion.

        Exclusion Criteria:

          -  Any TMJ internal derangement

          -  Inflammatory connective tissue disease

          -  Psychiatric problem

          -  Tumour

          -  Hearth disease or pacemaker

          -  Pregnancy

          -  Other orofacial region disease symptoms (e.g. toothache, neuralgia, migraine)

          -  Treatment or medication use for headache or bruxism in the last 2 years

          -  Local skin infection over the masseter or temporal muscle
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Doğan M, Ozdemir Doğan D, Düger C, Ozdemir Kol I, Akpınar A, Mutaf B, Akar T. Effects of high-frequency bio-oxidative ozone therapy in temporomandibular disorder-related pain. Med Princ Pract. 2014;23(6):507-10. doi: 10.1159/000365355. Epub 2014 Sep 3.</citation>
    <PMID>25196631</PMID>
  </reference>
  <reference>
    <citation>Daif ET. Role of intra-articular ozone gas injection in the management of internal derangement of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Jun;113(6):e10-4. doi: 10.1016/j.tripleo.2011.08.006. Epub 2012 Feb 28.</citation>
    <PMID>22677023</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2016</study_first_submitted>
  <study_first_submitted_qc>December 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 20, 2016</study_first_posted>
  <last_update_submitted>June 15, 2017</last_update_submitted>
  <last_update_submitted_qc>June 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Tamer Celakil</investigator_full_name>
    <investigator_title>Research Assistant</investigator_title>
  </responsible_party>
  <keyword>Ozone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Myalgia</mesh_term>
    <mesh_term>Temporomandibular Joint Disorders</mesh_term>
    <mesh_term>Temporomandibular Joint Dysfunction Syndrome</mesh_term>
    <mesh_term>Facial Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Salicylic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

